Op Ed: ICO에 대한 과도한 규제의 위험을 조심하십시오
blockchain-gaming
Bitcoin Magazine
Op Ed: Beware the Perils of Over-Regulation for ICOs
Last week, the U.S. Food and Drug Administration (FDA) approved the gene drug Kymriah for certain types of cancer. However, Kymriah costs $475,000 for one single treatment, Bloomberg reports, which is well beyond being affordable for average patients. In the U.S., the FDA approv
포인트 01
Bitcoin Magazine
Op Ed: Beware the Perils of Over-Regulation for ICOs
Last week, the U.S. Food and Drug Administration (FDA) approved the gene drug Kymriah for certain types of cancer. However, Kymriah costs $475,000 for one single treatment, Bloomberg reports, which is well beyond being affordable for average patients. In the U.S., the FDA approval process itself adds billions of dollars to drug development costs, which […]
This post Op Ed: Beware the Perils of Over-Regulation for ICOs first appeared on Bitcoin Magazine and is written by Giulio Prisco.
Bitcoin Magazine
Op Ed: Beware the Perils of Over-Regulation for ICOs
Last week, the U.S. Food and Drug Administration (FDA) approved the gene drug Kymriah for certain types of cancer. How
포인트 02
ever, Kymriah costs $475,000 for one single treatment, Bloomberg reports, which is well beyond being affordable for average patients. In the U.S., the FDA approval process itself adds billions of dollars to drug development costs, which […]
This post Op Ed: Beware the Perils of Over-Regulation for ICOs first appeared on Bitcoin Magazine and is written by Giulio Prisco.
Bitcoin Magazine
Op Ed: Beware the Perils of Over-Regulation for ICOs
Last week, the U.S. Food and Drug Administration (FDA) approved the gene drug Kymriah for certain types of cancer. However, Kymriah costs $475,000 for one single treatment, Bloomberg reports, which is well beyond being affordable for average patients. In the U.S., the FDA approval process itself adds billi
포인트 03
ons of dollars to drug development costs, which […]
This post Op Ed: Beware the Perils of Over-Regulation for ICOs first appeared on Bitcoin Magazine and is written by Giulio Prisco.
Bitcoin Magazine
Op Ed: Beware the Perils of Over-Regulation for ICOs
Last week, the U.S. Food and Drug Administration (FDA) approved the gene drug Kymriah for certain types of cancer. However, Kymriah costs $475,000 for one single treatment, Bloomberg reports, which is well beyond being affordable for average patients. In the U.S., the FDA approval process itself adds billions of dollars to drug development costs, which […]
This post Op Ed: Beware the Perils of Over-Regulation for ICOs first appeared on Bitcoin Magazine and is written by Giulio Prisco.
심층 분석
Bitcoin Magazine
Op Ed: Beware the Perils of Over-Regulation for ICOs
Last week, the U.S. Food and Drug Administration (FDA) approved the gene drug Kymriah for certain types of cancer. However, Kymriah costs $475,000 for one single treatment, Bloomberg reports, which is well beyond being affordable for average patients. In the U.S., the FDA approval process itself adds billions of dollars to drug development costs, which […]
This post Op Ed: Beware the Perils of Over-Regulation for ICOs first appeared on Bitcoin Magazine and is written by Giulio Prisco.
Bitcoin Magazine
Op Ed: Beware the Perils of Over-Regulation for ICOs
Last week, the U.S. Food and Drug Administration (FDA) approved the gene drug Kymriah for certain types of cancer. Ho
wever, Kymriah costs $475,000 for one single treatment, Bloomberg reports, which is well beyond being affordable for average patients. In the U.S., the FDA approval process itself adds billions of dollars to drug development costs, which […]
This post Op Ed: Beware the Perils of Over-Regulation for ICOs first appeared on Bitcoin Magazine and is written by Giulio Prisco.
Bitcoin Magazine
Op Ed: Beware the Perils of Over-Regulation for ICOs
Last week, the U.S. Food and Drug Administration (FDA) approved the gene drug Kymriah for certain types of cancer. However, Kymriah costs $475,000 for one single treatment, Bloomberg reports, which is well beyond being affordable for average patients. In the U.S., the FDA approval process itself adds bill
ions of dollars to drug development costs, which […]
This post Op Ed: Beware the Perils of Over-Regulation for ICOs first appeared on Bitcoin Magazine and is written by Giulio Prisco.
Bitcoin Magazine
Op Ed: Beware the Perils of Over-Regulation for ICOs
Last week, the U.S. Food and Drug Administration (FDA) approved the gene drug Kymriah for certain types of cancer. However, Kymriah costs $475,000 for one single treatment, Bloomberg reports, which is well beyond being affordable for average patients. In the U.S., the FDA approval process itself adds billions of dollars to drug development costs, which […]
This post Op Ed: Beware the Perils of Over-Regulation for ICOs first appeared on Bitcoin Magazine and is written by Giulio Prisco.